LICENSING OPTIONS. For each MIT Invention on which a patent application is filed by MIT, MIT hereby grants Sponsor a non-exclusive, non-transferable, royalty-free license for internal research purposes. Sponsor shall further be entitled to elect one of the following license options by notice in writing to MIT within six (6) months after MIT’s notification to Sponsor that a patent application has been filed:
1. a non-exclusive, non-transferable, royalty-free license (in a designated field of use, where appropriate) to Sponsor, without the right to sublicense, in the United States and/or any foreign country elected by Sponsor pursuant to Section 11.C below, to make, have made, use, lease, sell and import products embodying or produced through the use of such MIT Invention; or
2. a royalty-bearing, exclusive license (subject to third party rights, if any, and in a designated field of use, where appropriate) to Sponsor, including the right to sublicense, in the United States and/or any foreign country elected by Sponsor pursuant to Section 11.C below, to make, have made, use, lease, sell and import products embodying or produced through the use of such MIT Invention (or MIT’s interest in a Joint Invention). This option to elect an exclusive license is subject to MIT’s concurrence and the Parties’ negotiation of commercially reasonable license terms and conditions. Each of the foregoing licenses is subject to Sponsor’s agreement to (a) reimburse MIT for the costs of patent prosecution and maintenance in the United States and any elected foreign country, (b) demonstrate reasonable efforts to commercialize the technology in the public interest, and (c) comply with the requirements, if any, applicable under the Xxxx-Xxxx Xxx, 00 USC §200-212 and 37 CFR Part 401, as amended. If Sponsor and MIT do not enter into a license agreement within three (3) months after Sponsor’s election to proceed under Section 11.B.1 or 11.B.2 above, Sponsor’s rights under Sections 11.B.1 and 11.B.2 will expire.
LICENSING OPTIONS. 5.1 In accordance of Section 4 and the remainder of Section 5, it is anticipated that Intellectual Property resulting from the Sponsored Project, whether hardware or software, will be released under an open-source license. Any software code developed pursuant to this Sponsored Project shall be contributed and released pursuant to the Apache 2.0 or an equivalent permissive open-source license. For hardware, design files for the hardware shall be released under a copyleft license once any Intellectual Property has been disclosed, reviewed, and potentially protected under Sections 4 and 5 of this agreement. This license will be under the CERN Open Hardware License, the TAPR Open Hardware License, or an equivalent open-source hardware license.
5.2 Sponsor’s Evaluation of AURI’s Intellectual Property. Intellectual Property owned by AURI resulting from the Sponsored Project disclosed by AURI to Sponsor may be used by Sponsor on a non-exclusive royalty-free basis, solely for internal research purposes to evaluate whether or not Sponsor is interested in licensing the technology from AURI.
LICENSING OPTIONS. The Licensing Options are as follows: • Harmony Single Site license (monthly) • Harmony Single Site license (yearly) Both licensing options include: • Application hosting • Data back up • Automatic software upgrades • Online video training and documents (Learning Path) • Online technical support • Phone support • CCS interface
LICENSING OPTIONS. For each UNIVERSITY Invention on which a patent application is filed by UNIVERSITY, UNIVERSITY hereby grants FARDA a non-exclusive, non-transferable, royalty-free license for non- commercial internal research purposes. FARDA shall further be entitled to elect an option to the following commercial license by notice in writing to UNIVERSITY within three (3) months after UNIVERSITY’s notification to FARDA that a patent application has been filed:
(i) a royalty-bearing, limited-term, exclusive license (subject to third party rights, if any, and in a designated field of use, where appropriate) to FARDA, including the right to sublicense, in the United States and/or any foreign country elected by FARDA pursuant to Section 8.3.c. below, to make, have made, use, lease, sell and import products embodying or produced through the use of such invention. This option to elect an exclusive license is subject to UNIVERSITY’s concurrence, and the negotiation of commercially reasonable license terms and conditions, and is conditioned upon FARDA’s payment to UNIVERSITY for the costs of patent prosecution and maintenance in the United States, and any elected foreign country, and to cause any products produced pursuant to this license that will be used or sold in the United States to be substantially manufactured in the United States. If FARDA and UNIVERSITY do not enter into a license agreement within three (3) months after FARDA’s election to proceed under paragraph 8.3.b(i) above, FARDA’s rights under paragraph 8.3.b(i) will expire.
LICENSING OPTIONS a. Hindenburg offers 2 licensing options:
I. Subscription licensing:
i. a licence acquired by pre-paying a licensing fee, either monthly or annually.
ii. includes access to the latest released version of the licensed Product.
iii. licensing period begins as soon as your initial payment is processed.
iv. renews automatically monthly or annually, according to the subscription option chosen by the Licensee, without notice, until renewal is cancelled by the Licensee.
LICENSING OPTIONS a. Xxxxxxxxxx offers the following licensing options for Hindenburg Products:
i. Subscription licensing:
(i) a licence acquired by pre-paying a recurring licensing fee, either monthly or annually.
(ii) multiple subscription tiers are offered, which include differentiated access to Hindenburg Services within a subscription period. See current product description on Xxxxxxxxxx’s website for details.
(iii) when upgrading to a higher tier, the value of the remaining time on the current subscription is pro-rated to the end of the current period, and the difference is charged for that same period at the rate of the higher tier, until the end of the current subscription period. Thereafter the new pricing tier is charged.
(iv) when downgrading or cancelling a subscription before the end of a subscription period, the change goes into effect on the renewal date of the current subscription.
(v) includes access to the latest released version of the licensed Product.
(vi) licensing period begins as soon as your initial payment is processed.
(vii) renews automatically monthly or annually, according to the subscription option chosen by the Licensee, without notice, until renewal is cancelled by the Licensee.
ii. Perpetual licensing:
(i) a licence acquired by paying a fixed, one-time licensing fee.
(ii) allows access to a named Hindenburg Product in perpetuity, in the released version and compatible with the operating system versions supported by the Product at time of licensing.
(iii) includes updates to that version, up to and including a pre-set version number as noted in the licensing terms at the time of licence acquisition.
(iv) at the publication time of this XXXX, that includes: − for HNS: all updates up to and including version 1.99. − for HPS acquired ON OR AFTER February 13th 2023: all updates up to, and including version 2.99. − for HPS acquired BEFORE February 13th 2023: all updates up to, and including version 1.99.
(v) when Xxxxxxxxxx launches a new version, an upgrade path may be offered to the new version. Xxxxxxxxxx does not warrant that this will be as a Perpetual licensing option.
LICENSING OPTIONS. The University hereby grants to Sponsor the exclusive right and option to negotiate with the University for an exclusive, worldwide, right and license to make, have made, use and sell commercial products embodying any University Invention(s), with the right to sublicense, for the lives of any patent issuing thereon, upon commercially reasonable terms. The Sponsor and the University shall exercise reasonable efforts to agree to terms and conditions of such a license within sixty (60) days after Sponsor's receipt of notice and disclosure of a University Invention from the University. If, after the end of the sixty (60) day period (or such additional period if agreed by both parties), Sponsor and the University are unable to reach agreement on the terms of such a license, the University shall thereafter be free to engage in license discussions and negotiations with third parties regarding such University Invention(s).
LICENSING OPTIONS. For each UNIVERSITY Invention on which a patent application is filed by UNIVERSITY, UNIVERSITY hereby grants the SPONSOR a non-exclusive, non- transferable, royalty-free license for non-commercial internal research purposes. The SPONSOR shall further be entitled to elect an option to the following commercial license by notice in writing to UNIVERSITY within three (3) months after UNIVERSITY’s notification to the SPONSOR that a patent application has been filed:
(i) a royalty-bearing, limited-term, exclusive license (subject to third party rights, if any, and in a designated field of use, where appropriate) to the SPONSOR, including the right to sublicense, in the United States and/or any foreign country elected by the SPONSOR pursuant to Section 8.3.c. below, to make, have made, use, lease, sell and import products embodying or produced through the use of such invention. This option to elect an exclusive license is subject to UNIVERSITY’s concurrence, and the negotiation of commercially reasonable license terms and conditions, and is conditioned upon SPONSOR’s payment to UNIVERSITY for the costs of patent prosecution and maintenance in the United States, and any elected foreign country, and to cause any products produced pursuant to this license that will be used or sold in the United States to be substantially manufactured in the United States. If the SPONSOR and UNIVERSITY do not enter into a license agreement within three (3) months after the SPONSOR’s election to proceed under paragraph 8.3.b(i) above, the SPONSOR’s rights under paragraph 8.3.b(i) will expire.
LICENSING OPTIONS. Each of the Medical Colleges grants to the Sponsor an exclusive ninety (90) day option (from date of notification of the Medical Colleges Invention) to negotiate for the acquisition of a license, to such Medical Colleges Inventions on reasonable terms and conditions to be negotiated in good faith between Medical Colleges and Sponsor. If there is no agreement on license terms during the ninety (90) day period following Sponsor’s notification that it wishes to exercise its option, Medical Colleges shall be free to offer commercial license rights to third parties.
LICENSING OPTIONS. The Medical College hereby grants to Sponsor the exclusive right and option to negotiate with the Medical College for an exclusive, worldwide, right and license to make, have made, use and sell commercial products embodying any Medical College Invention(s), with the right to sublicense, for the lives of any patent issuing thereon, upon commercially reasonable terms. The Sponsor and the Medical College shall exercise reasonable efforts to agree to terms and conditions of such a license within sixty (60) days after Sponsor’s receipt of notice and disclosure of a Medical College Invention from the Medical College. If, after the end of the sixty (60) day period (or such additional period if agreed by both parties), Sponsor and the Medical College are unable to reach agreement on the terms of such a license, the Medical College shall thereafter be free to engage in license discussions and negotiations with third parties regarding such Medical College Invention(s).
